Omaha, NE · Founded 2015 · Privately Held (backing)
Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery. Centese is based in Omaha, NE and was founded in 2015. Its last reported valuation was $40.1 million in Nov 2023. It has raised $30.5 million across 3 recorded rounds; the latest was a $250,000 seed round in May 2026.
Last reported valuation
$40.1M
Oct 2026
Priced at
—
Total raised
$30.5M
Last round
Seed Round
May 2026
No prints on record
No secondary trades in Centese shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Centese with a free account
·The complete investor list: 17 names
·Watch Centese: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Centese stock.
